OR2H5P

Across TCGA pan-cancer cohorts, OR2H5P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated OR2H5P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher OR2H5P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR2H5P expression acts as an unfavorable survival marker, although some lineages such as LGG and GBM show a favorable association.

THCA, KIRC, and THYM are the cancer types where OR2H5P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.554	0.950	<.001	78	view →
KIRC	OS	Tertile	All	0.729	0.820	.003	54	view →
THYM	OS	Tertile	All	0.655	0.992	<.001	54	view →
LGG	OS	Median	All	0.873	0.743	<.001	39	view →
GBM	OS	Median	All	0.474	0.342	.002	21	view →
KIRP	OS	Tertile	II,III,IV	0.208	0.782	.003	18	view →
CESC	OS	Tertile	III,IV	0.279	0.678	.026	18	view →
COAD	OS	Tertile	III,IV	0.385	0.710	.021	12	view →
OV	OS	Tertile	All	0.784	0.675	.028	12	view →
LIHC	DFS	Tertile	III,IV	0.139	0.352	.015	12	view →
CHOL	OS	Tertile	All	0.837	0.274	.008	9	view →
DLBC	DFS	Tertile	II,III,IV	0.373	0.836	.027	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

OR2H5P–THCA (OS)

Open the THCA breakdown →